Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Pseudomos aeruginosa Pneumonia - Overview
Pseudomos aeruginosa Pneumonia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Pseudomos aeruginosa Pneumonia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Pseudomos aeruginosa Pneumonia - Companies Involved in Therapeutics Development
Aridis Pharmaceuticals Inc
AstraZeneca Plc
Ayuvis Research Inc
Pedanius Therapeutics Ltd
Pseudomos aeruginosa Pneumonia - Drug Profiles
AVR-86 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy for Pseudomos aeruginosa Pneumonia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
panobacumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PED-014 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PED-015 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PED-019 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombint Enzyme for Pseudomos Aeruginosa Pneumonia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Pseudomos aeruginosa Pneumonia - Dormant Projects
Pseudomos aeruginosa Pneumonia - Discontinued Products
Pseudomos aeruginosa Pneumonia - Product Development Milestones
Featured News & Press Releases
Sep 26, 2017: Study Investigates Novel Immunotherapeutic Delivery Strategy for Preventing Infection with Antibiotic Resistant Bacteria
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Pseudomonas aeruginosa Pneumonia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Pseudomonas aeruginosa Pneumonia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Pseudomonas aeruginosa Pneumonia - Pipeline by Aridis Pharmaceuticals Inc, H2 2020
Pseudomonas aeruginosa Pneumonia - Pipeline by AstraZeneca Plc, H2 2020
Pseudomonas aeruginosa Pneumonia - Pipeline by Ayuvis Research Inc, H2 2020
Pseudomonas aeruginosa Pneumonia - Pipeline by Pedanius Therapeutics Ltd, H2 2020
Pseudomonas aeruginosa Pneumonia - Dormant Projects, H2 2020
Pseudomonas aeruginosa Pneumonia - Discontinued Products, H2 2020